Description
Ostarine (MK-2866) + Cardarine (GW-501516) Stack research stack
Ostarine + Cardarine Stack combines the SARM Ostarine with the PPAR-δ agonist Cardarine, as tablets or capsules.
Product details
| Compound | Ostarine (MK-2866) and Cardarine (GW-501516) |
|---|---|
| Class | SARM + PPAR-δ agonist stack |
| Form | Tablets; Capsules |
| Strength | 20mg/27ct/540mg; 20mg/54ct/1080mg; 20mg/60ct/1.2g |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Ostarine: androgen receptor research.
- Cardarine: PPAR-δ research.
- Comparative research: distinct targets.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
S4 Andarine + Ostarine (MK-2866) Stack · S4 Andarine + Cardarine (GW-501516) Stack · Ostarine (MK-2866) · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.